CounterACT Funding Opportunity Q&A Informational Webinar

CounterACT Funding Opportunity Q&A Informational Webinar

March 27, 2019
March 27, 2019

Contact: 

Timothy Lyden

Contact Email: 

timothy.Lyden@nih.gov

Location: 

Register to join the Online Webinar
Phone: 650-479-3209
Access Code: 626 322 885

Event Description: 

The NIH CounterACT program supports basic and translational research aimed at understanding the fundamental mechanisms of toxicity caused by chemical threat agents and the application of this knowledge to develop promising therapeutics for reducing mortality and morbidity caused by these agents.

This NIH-led program includes a comprehensive network of Research Centers of Excellence, individual co-operative research projects, small business innovation research grants, contracts, and interagency agreements with the Department of Defense.

We are hosting a free webinar to explain the current NIH CounterACT funding opportunity announcements (see links below), application best practices, support offered by the program, as well as answer questions from the audience.

PAR-18-721: Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed)

PAR-10-039: Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)

PAR-19-040: Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)

PAR-18-657: Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)

You can also submit questions before the meeting to timothy.Lyden@nih.gov.  While you can listen to the meeting by phone by dialing 1650-479-3209 Access Code 626 322 885, all questions will need to be submitted online.

Webinar will be led by the NIH CounterACT Program Director, David A. Jett, PhD.